These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7990105)
61. [Angiotensin-II receptor blockers]. Metelitsa VI Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837 [No Abstract] [Full Text] [Related]
62. Synthesis and antihypertensive activity of imidazo[2,1-b]-thiazoles bearing a 2,6-dichlorophenyl group. Andreani A; Rambaldi M; Locatelli A; Cristoni A; Malandrino S; Pifferi G Acta Pharm Nord; 1992; 4(2):93-6. PubMed ID: 1388775 [TBL] [Abstract][Full Text] [Related]
63. Regression of hypertrophy after myocardial infarction is produced by the chronic blockade of angiotensin type 1 receptor in rats. Makino N; Hata T; Sugano M; Dixon IM; Yanaga T J Mol Cell Cardiol; 1996 Mar; 28(3):507-17. PubMed ID: 9011634 [TBL] [Abstract][Full Text] [Related]
64. A potent, orally active, balanced affinity angiotensin II AT1 antagonist and AT2 binding inhibitor. de Laszlo SE; Quagliato CS; Greenlee WJ; Patchett AA; Chang RS; Lotti VJ; Chen TB; Scheck SA; Faust KA; Kivlighn SS J Med Chem; 1993 Oct; 36(21):3207-10. PubMed ID: 8230109 [No Abstract] [Full Text] [Related]
65. Antihypertensive and hormonal activity of MK 954 in spontaneously hypertensive rats. Mizuno K; Niimura S; Tani M; Haga H; Gomibuchi T; Sanada H; Fukuchi S Eur J Pharmacol; 1992 May; 215(2-3):305-8. PubMed ID: 1396995 [TBL] [Abstract][Full Text] [Related]
66. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652 [TBL] [Abstract][Full Text] [Related]
67. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]
68. 1-(carboxybenzyl)imidazole-5-acrylic acids: potent and selective angiotensin II receptor antagonists. Weinstock J; Keenan RM; Samanen J; Hempel J; Finkelstein JA; Franz RG; Gaitanopoulos DE; Girard GR; Gleason JG; Hill DT J Med Chem; 1991 Apr; 34(4):1514-7. PubMed ID: 2016730 [No Abstract] [Full Text] [Related]
69. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. Blankley CJ; Hodges JC; Klutchko SR; Himmelsbach RJ; Chucholowski A; Connolly CJ; Neergaard SJ; Van Nieuwenhze MS; Sebastian A; Quin J J Med Chem; 1991 Nov; 34(11):3248-60. PubMed ID: 1956044 [TBL] [Abstract][Full Text] [Related]
70. Balanced AT1/AT2 receptor antagonists. 4. XR510 and related 5-(3-amidopropanoyl)imidazoles possessing equal affinity for the AT1 and AT2 receptors. Quan ML; Chiu AT; Ellis CD; Wong PC; Wexler RR; Timmermans PB J Med Chem; 1995 Jul; 38(15):2938-45. PubMed ID: 7636854 [TBL] [Abstract][Full Text] [Related]
71. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats. Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683 [TBL] [Abstract][Full Text] [Related]
72. Pulmonary edema induced by angiotensin II in rats. Shimakura K; Sanaka M; Wang L; Mineshita S; Miyazaki M Jpn J Pharmacol; 1995 Apr; 67(4):383-9. PubMed ID: 7650872 [TBL] [Abstract][Full Text] [Related]
73. Imidazole derivatives. IV. Synthesis and pharmacologic activity of oxygenated derivatives of imidazo(1,2-a)pyridine. Almirante L; Mugnaini A; De Toma N; Gamba A; Murmann W J Med Chem; 1970 Nov; 13(6):1048-51. PubMed ID: 4991390 [No Abstract] [Full Text] [Related]
74. Connective eccentricity index: a novel topological descriptor for predicting biological activity. Gupta S; Singh M; Madan AK J Mol Graph Model; 2000 Feb; 18(1):18-25. PubMed ID: 10935202 [TBL] [Abstract][Full Text] [Related]
75. 6-Substituted 5-chloro-1,3-dihydro-2H-imidazo(4,5-b)pyrazin-2-ones with hypotensive activity. Jones JH; Holtz WJ; Cragoe EJ J Med Chem; 1973 May; 16(5):537-42. PubMed ID: 4352334 [No Abstract] [Full Text] [Related]
76. Dihydropyridines with potent hypotensive activity prepared by the Hantzsch reaction. Loev B; Ehrreich SJ; Tedeschi RE J Pharm Pharmacol; 1972 Nov; 24(11):917-8. PubMed ID: 4405663 [No Abstract] [Full Text] [Related]
77. Amidines. 4. Synthesis of tricyclic guanidines related to 1,2,3,5-tetrahydroimidazo(2,1-b)quinazoline, a new antihypertensive agent. Jen T; Bender P; Van Hoeven H; Dienel B; Loev B J Med Chem; 1973 Apr; 16(4):407-11. PubMed ID: 4716186 [No Abstract] [Full Text] [Related]
78. Cognitive enhancing actions of PD123177 detected in a mouse habituation paradigm. Barnes NM; Costall B; Kelly ME; Murphy DA; Naylor RJ Neuroreport; 1991 Jun; 2(6):351-3. PubMed ID: 1912468 [TBL] [Abstract][Full Text] [Related]